[Retracted] Identification and Potential Mechanisms of a 7-MicroRNA Signature That Predicts Prognosis in Patients with Lower-Grade Glioma

Figure 2

(a) The distribution of survival time and survival status among the two risk groups in the training, testing, and entire cohorts. The dotted line indicates the median cutoff point of the risk score that has been used for stratifying individuals with LGG into two groups of high and low risk. (b) The curves of Kaplan–Meier are dependent of the microRNA-based risk assessment model in the testing cohort, training cohort, and entire cohort of the low- and high-risk patients. (c) Representation of ROC line curves in the testing, entire, and training cohorts.

(a)

(b)

(c)